Navigation Links
Ortho-McNeil initiates first-of-its-kind skin infection registry
Date:8/6/2008

lth, 111,000 people with diabetes are hospitalized with foot infections each year, and as many as 3.09 million adults will develop a diabetic foot infection in their lifetime.

The increased incidence of one of the most common resistant bacteria that are causing cSSTI, methicillin-resistant Staphylococcus aureus (MRSA), poses a significant challenge and burden to the U.S. health care system. Despite the high incidence of cSSTIs, a limited understanding remains and a wide variety of treatment options are used which often affect patient outcomes.

The emergence of resistant bacteria has created a need for new antibiotics and treatment strategies. As such, treatment choices made by physicians can significantly impact how patients with cSSTI respond to care.


'/>"/>

Contact: Amy Firsching
908-218-7583
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
2. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
3. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
4. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
5. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
6. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
7. Harbinger Research Initiates Coverage on HearAtLast
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
10. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
11. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Research Center for Healthy Neighborhoods (PRCHN) at Case ... key player in nearly $13.32 million in federal ... Ohio. , The Centers for Disease Control and ... million over five years. The funds will support ... disseminating individual, environmental, and policy interventions that prevent ...
(Date:10/31/2014)... Denver, Colorado (PRWEB) October 31, 2014 Daily ... new method is actually described as the fastest fat loss ... results in less than a month. , There is no ... fat loss eBook of all time. The new nutrition and ... popular nutrition and fitness expert. , According to the ...
(Date:10/31/2014)... Missouri (PRWEB) October 31, 2014 At ... country about families narrowly escaping carbon monoxide poisoning in ... looms just weeks away, one family-owned, Missouri-based heating and ... approach to making sure families start the home heating ... safe and secure. , Beginning Nov. 1, 2014, ...
(Date:10/31/2014)... Tampa, FL (PRWEB) October 31, 2014 ... Infrared-Active compression gear. The new gear is now available ... information on the benefits of Celliant infrared-active athletic gear ... recently reported that another contract has been signed for ... Olympic speedskaters for the next eight years. In light ...
(Date:10/31/2014)... News) -- Obesity increases the risk of certain types ... two new U.S. studies show. One study of ... obese increased the risk for estrogen receptor-negative and progesterone ... this for a long time for white women, but ... study author Esther John, a senior research scientist at ...
Breaking Medicine News(10 mins):Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 3Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2
... ... ... ... ...
... ... dietary supplements, including two popular weight loss supplements, according to new tests by ... weight loss products and ConsumerLab.com noted concern for potential side-effects from products containing ... 7-keto DHEA supplements. , ...
... , ... blasts away the pounds in a fitness competition to claim coveted tech prizes. , ... Salt Lake City, UT (Vocus) March 3, 2010 ... shape up – just a few, sweet tech prizes., , , , ,"Mention ,iPad, or ,Dell ...
... ... 25 recipient list for the 2010 Diversity Council Honors Award™. The recipients’ rankings ... 2010 Linkage Summit on Leading Diversity Conference, April 27 in Atlanta. , ... (PRWEB) March 4, 2010 -- The ...
... ... ... -- Brown Dog Foundation , a Nashville-based nonprofit dedicated to helping pets in need ... Cat Competition. In this 10-week fundraising campaign, dogs and cats vie for the coveted title ...
... ... ... ... ...
Cached Medicine News:Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 2Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 3Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 4Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 5Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 6Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 7Health News:Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing 8Health News:ConsumerLab.com Finds Carcinogenic form of Chromium in Supplements, Including Those for Weight Loss 2Health News:ConsumerLab.com Finds Carcinogenic form of Chromium in Supplements, Including Those for Weight Loss 3Health News:ConsumerLab.com Finds Carcinogenic form of Chromium in Supplements, Including Those for Weight Loss 4Health News:SEO.com Slims Down in Company Fitness Contest 2Health News:The Association of Diversity Councils Announces Its 2010 Diversity Council Honors Award™ Recipients 2Health News:The Association of Diversity Councils Announces Its 2010 Diversity Council Honors Award™ Recipients 3Health News:ATTENTION: Pawty Animals Needed in Nashville, Tennessee 2Health News:ATTENTION: Pawty Animals Needed in Nashville, Tennessee 3Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 2Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 3Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 4Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 5
(Date:10/30/2014)... 30, 2014 WuXi PharmaTech (Cayman) Inc. (NYSE: ... technology platform company serving the pharmaceutical, biotechnology, and medical ... and the United States , ... the Tel Aviv area of ... WuXi,s broad platform of integrated R&D services to local ...
(Date:10/30/2014)... Boston Scientific Corporation (NYSE: BSX ... Suisse Annual Healthcare Conference on Tuesday, November 11, 2014 ... Brennan , executive vice president and chief financial officer, ... approximately 8:00 a.m. PT followed by a question and ... presentation and question and answer session will be available ...
(Date:10/30/2014)... , Oct. 30, 2014   ViaDerma, Inc. ... to bringing new products to market, has recently ... TetraStem. TetraStem is a topical liquid tetracycline-based antibiotic ... that can convert oral medication active ingredients into ... a first aid antibiotic to help prevent skin ...
Breaking Medicine Technology:WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3
... 27, 2011 Pepto-Bismol announced today that for the second ... white and … PINK? In an act of true gastro-patriotism, ... Nathan,s Famous Fourth of July International Hot Dog Eating Contest ... To make this contest a celebration to remember, Pepto-Bismol has ...
... Recent findings published in the scientific journal Leukemia ... with standard anti-leukemia agents, the biological activity of Leukothera ... Biomed, Inc., showed synergistic anti-leukemia effects. ... demonstrated that combining Leukothera TM with ...
Cached Medicine Technology:Pepto-Bismol and Nick Cannon Heat Things up at this Year's Nathan's Famous Fourth of July International Hot Dog Eating Contest 2Pepto-Bismol and Nick Cannon Heat Things up at this Year's Nathan's Famous Fourth of July International Hot Dog Eating Contest 3Recent Study Shows Leukothera™ Combined with Other Agents Has Enhanced Anti-Leukemia Effects 2
... is a neurosurgical OR that fully ... tools, including iMRI, necessary to treat ... neurosurgical treatments are performed in a ... for MR compatibility and safety, BrainSUITE ...
... Quality EEG recording is assured even in ... has high performance, high sensitivity amplifiers, ... rejection filter, shielded electrodes and a high ... Neurofax is a complete and ready ...
... the world's first Windows 2000 notebook ... It allows data sharing with other ... with Microsoft Office 2000. Data and ... the large, sharp 14.1-inch TFT screen ...
... Physiological lesion assessment using Fractional ... proven and cost effective solution ... location of stenosis). Radi's new ... offer fast, easy and accurate ...
Medicine Products: